Composition pour le traitement de troubles inflammatoires

Zusammensetzung zur Behandlung entzündlicher Erkrankungen

Composition for treatment of inflammatory disorders

Abstract

A pharmaceutical composition for parenteral administration, comprising liposomes composed of non-charged vesicle-forming lipids, optionally including not more than 5 mole percent of charged vesicle-forming lipids, the liposomes having a selected mean particle diameter in the size range between about 40 - 200 nm and containing a water soluble corticosteroid for the site-specific treatment of inflammatory disorders, is provided.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (7)

    Publication numberPublication dateAssigneeTitle
    EP-0622072-A2November 02, 1994Wakamoto Pharmaceutical Co., Ltd.Dispersions aqueuses stables contenant des liposomes
    EP-1190706-A1March 27, 2002Terumo Kabushiki KaishaLiposomes
    US-5853752-ADecember 29, 1998Imarx Pharmaceutical Corp.Methods of preparing gas and gaseous precursor-filled microspheres
    US-6316260-B1November 13, 2001Bernina Biosystems GmbhTetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof
    WO-0038653-A1July 06, 2000Idea Ag.Formulation amelioree pour l'application topique non invasive in vivo
    WO-0245688-A2June 13, 2002Universiteit Utrecht Holding B.V.Composition for treatment of inflammatory disorders
    WO-9407466-A1April 14, 1994Liposome Technology, Inc.Compositions for treatmewnt of inflamed tissues

NO-Patent Citations (2)

    Title
    AL-MUHAMMAD J ET AL: "STUDIES ON THE FORMULATION AND IN VITRO RELEASE OF OPHTHALMIC LIPOSOMES CONTAINING DEXAMETHASONE SODIUM PHOSPHATE" JOURNAL OF MICROENCAPSULATION, vol. 13, no. 2, 1996, pages 123-130, XP009000578
    FARSHI F S ET AL: "IN-VIVO STUDIES IN THE TREATMENT OF ORAL ULCERS WITH LIPOSOMAL DEXAMETHASONE SODIUM PHOSPHATE" JOURNAL OF MICROENCAPSULATION, vol. 13, no. 5, 1996, pages 537-544, XP000599286

Cited By (6)

    Publication numberPublication dateAssigneeTitle
    EP-2127639-A1December 02, 2009Universiteit Utrecht Holding B.V., Mount Sinai School of Medicine of New York UniversityCorticosteroid containing liposomes for treatment of cardiovascular diseases
    US-2011189266-A1August 04, 2011Mount Sinai School Of Medicine Of New York University, Universiteit Utrecht Holdings B.V.Corticosteroid microvesicles for treatment of cardiovascular diseases
    WO-2004047792-A2June 10, 2004Novosom AgLiposomal glucocorticoids
    WO-2004047792-A3August 12, 2004Novosom Ag, Steffen Panzner, Rolf Braeuer, Raimund W Kinne, Una RauchhausLiposomale glucocorticoide
    WO-2006081354-A2August 03, 2006Celator Pharmaceuticals, Inc.Lipid carrier compositions with reduced polydispersity
    WO-2006081354-A3December 07, 2006Celator Pharmaceuticals Inc, Paul Tardi, Lawrence Mayer, Donna Cabral-LillyLipid carrier compositions with reduced polydispersity